Update on ADAMTS13 and VWF in cardiovascular and hematological disorders

被引:33
作者
Akyol, Omer [1 ,2 ]
Akyol, Sumeyya [1 ]
Chen, Chu-Huang [1 ,2 ,3 ,4 ]
机构
[1] Texas Heart Inst, Vasc & Med Res, Houston, TX 77025 USA
[2] Hacettepe Univ, Dept Med Biochem, Fac Med, Ankara, Turkey
[3] Kaohsiung Med Univ, Lipid Sci & Aging Res Ctr, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ Hosp, Ctr Lipid Biosci, Kaohsiung, Taiwan
关键词
ADAMTS13; von Willebrand factor; Thrombotic thrombocytopenic purpura; Arterial thrombosis; Cardiovascular diseases; Hematological diseases; VON-WILLEBRAND-FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; FACTOR-CLEAVING PROTEASE; ACUTE MYOCARDIAL-INFARCTION; CONGENITAL HEART-DISEASE; UPSHAW-SCHULMAN-SYNDROME; VASCULAR ENDOTHELIAL-CELLS; C-REACTIVE PROTEIN; ATRIAL-FIBRILLATION; ISCHEMIC-STROKE;
D O I
10.1016/j.cca.2016.10.017
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Endothelial cells (EC) respond to injury by releasing numerous factors, including von Willebrand factor (VWF). High circulating levels of unusually large VWF multimers (UL-VWFM) have strong procoagulant activity and facilitate platelet adhesion and aggregation by interacting with platelets after an acute event superimposed on peripheral arterial disease and coronary artery disease. ADAMTS13-a disintegrin-like metalloproteinase with thrombospondin motif type 1 member 13 regulates a key physiological process of coagulation in the circulation by cleaving VWF multimers into small, inactive fragments. Low levels of ADAMTS13 in the blood may play a role in cardiovascular and hematological disorders, and clarifying its role may help improve disease management. The genetic, pharmacological, physiological, and pathological aspects related to ADAMTS13/VWF have been extensively investigated. Here, we provide an update on recent findings of the relationship between ADAMTS13 and hematological/cardiovascular disorders, including thrombotic thrombocytopenic purpura, arterial thrombosis, thrombotic microangiopathy, myocardial infarction, ischemic stroke, heart failure, and hypertension. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:109 / 118
页数:10
相关论文
共 107 条
[1]  
Akyol S, 2014, B CLIN PSYCHOPHARMAC, V24, P323
[2]   Left Atrial Blood Stasis and Von Willebrand Factor-ADAMTS13 Homeostasis in Atrial Fibrillation [J].
Ammash, Naser ;
Konik, Ewa A. ;
McBane, Robert D. ;
Chen, Dong ;
Tange, Julie I. ;
Grill, Diane E. ;
Herges, Regina M. ;
McLeod, Thomas G. ;
Friedman, Paul A. ;
Wysokinski, Waldemar E. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (11) :2760-2766
[3]   High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women [J].
Andersson, Helena M. ;
Siegerink, Bob ;
Luken, Brenda M. ;
Crawley, James T. B. ;
Algra, Ale ;
Lane, David A. ;
Rosendaal, Frits R. .
BLOOD, 2012, 119 (06) :1555-1560
[4]   Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura [J].
Banno, F ;
Kokame, K ;
Okuda, T ;
Honda, S ;
Miyata, S ;
Kato, H ;
Tomiyama, Y ;
Miyata, T .
BLOOD, 2006, 107 (08) :3161-3166
[5]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[6]   Uncontrolled immune response in acute myocardial infarction: Unraveling the thread [J].
Bodi, Vicente ;
Sanchis, Juan ;
Nunez, Julio ;
Mainar, Luis ;
Minana, Gema ;
Benet, Isabel ;
Solano, Carlos ;
Chorro, Francisco J. ;
Llacer, Angel .
AMERICAN HEART JOURNAL, 2008, 156 (06) :1065-1073
[7]   Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients [J].
Bongers, T. N. ;
de Bruijne, E. L. E. ;
Dippel, D. W. J. ;
de Jong, A. J. ;
Deckers, J. W. ;
Poldermans, D. ;
de Maat, M. P. M. ;
Leebeek, F. W. G. .
ATHEROSCLEROSIS, 2009, 207 (01) :250-254
[8]   High von Willebrand factor levels increase the risk of first ischemic stroke -: Influence of ADAMTS13, inflammation, and genetic variability [J].
Bongers, Tamara N. ;
de Maat, Moniek P. M. ;
van Goor, Mary-Lou P. J. ;
Bhagwanbali, Vinod ;
van Vilet, Huub H. D. M. ;
Garcia, Encarna B. Gomez ;
Dippel, Diederik W. J. ;
Leebeek, Frank W. G. .
STROKE, 2006, 37 (11) :2672-2677
[9]  
Camilleri RS, 2008, J THROMB HAEMOST, V6, P331, DOI 10.1111/j.1538-7836.2008.02846.x
[10]   A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom [J].
Camilleri, R. S. ;
Scully, M. ;
Thomas, M. ;
Mackie, I. J. ;
Liesner, R. ;
Chen, W. J. ;
Manns, K. ;
Machin, S. J. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (09) :1792-1801